You are here: Industry Insights > AstraZeneca

News List

AstraZeneca’s Covid-19 vaccine gets EUA in Philippines pharmaceutical-technology
February 01, 2021
AstraZeneca has obtained emergency use authorisation (EUA) from the Philippines Food and Drug Administration (FDA) for its Covid-19 vaccine, granted following a detailed review by medical and regulatory experts in the country.
COVID-19 vaccines supply may meet, even exceed demand in India by third quarter: AstraZeneca India Head expresspharma
February 01, 2021
For any vaccine to be meaningful in the current pandemic, it has to be made available broadly, equitably and timely, he said.
AstraZeneca-Oxford COVID-19 vaccine approved in EU expresspharma
February 01, 2021
The AstraZeneca vaccine demonstrated efficacy of around 60 per cent in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement.
Mexico to buy AstraZeneca vaccine from India: President Andres Manuel Lopez Obrador expresspharma
February 01, 2021
Mexico also has a deal with AstraZeneca to produce its vaccine for distribution in Latin America, with financial support from the foundation of Mexican billionaire Carlos Slim.
AZ/Daiichi Sankyo’s antibody drug conjugates prove promising in early trials pharmatimes
January 29, 2021
AstraZeneca (AZ) and Daiichi Sankyo have posted new data from Phase I/II trials evaluating their respective antibody drug conjugates (ADCs) Enhertu (trastuzumab deruxtecan) and datopotamab deruxtecan.
AstraZeneca secures China approval for treating mild asthma with Symbicort Turbuhaler pharmaceutical-business-review
January 29, 2021
AstraZeneca announced that it has secured regulatory approval from China’s National Medical Products Administration (NMPA) for Symbicort Turbuhaler, an anti-inflammatory reliever to relieve symptoms of mild asthma.
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial contractpharma
January 27, 2021
Care Access to provide decentralized, mobile research site operations for AstraZeneca’s AZD7442 Phase III trial in the U.S.
Fiocruz Institute, Brazil commences distribution of India-made AstraZeneca COVID-19 vaccine expresspharma
January 25, 2021
Until now, Brazil’s vaccine rollout has depended on a shot developed by Sinovac Biotech vaccine in partnership with Sao Paulo’s Butantan Institute.
Italy to take legal action against Pfizer, AstraZeneca over COVID-19 vaccine delays expresspharma
January 25, 2021
The aim was to get the companies to meet the vaccine volumes they had promised and not to seek compensation, said Foreign Minister Luigi Di Maio.
Enhertu bags EU approval for HER2-positive breast cancer pharmatimes
January 21, 2021
AstraZeneca and Daiichi Sankyo’s HER2-targeting antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has been granted a conditional approval in the EU.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page